A case study on the value of access to novel therapies through clinical trials
Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant
Surprising outcome differs from previous results
A closer look at other T-cell subsets
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dedication to ongoing clinical care and research